A simple vector modification to facilitate oligonucleotide-directed mutagenesis.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 331175)

Published in Nucleic Acids Res on July 25, 1990

Authors

D R Setzer1, R M Hmiel, S Y Liao

Author Affiliations

1: Department of Molecular Biology and Microbiology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106.

Articles by these authors

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol (1999) 5.53

Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol (2001) 2.86

Human papillomaviruses and cervical cancer: analysis of histopathologic features associated with different viral types. Hum Pathol (1988) 1.95

Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity. Am J Pathol (1998) 1.71

Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol (1994) 1.68

Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype. Pharmacogenetics (2000) 1.55

Second-look laparotomy in ovarian germ cell tumors: the gynecologic oncology group experience. Gynecol Oncol (1994) 1.55

Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res (2001) 1.55

Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol (1993) 1.47

BRCA1 R841W: a strong candidate for a common mutation with moderate phenotype. Genet Epidemiol (1996) 1.45

Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.44

beta-Carotene treatment of cervical intraepithelial neoplasia: a phase II study. Cancer Epidemiol Biomarkers Prev (1996) 1.43

Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol (1990) 1.42

Verruciform xanthoma of the ear with coexisting epidermal dysplasia. Am J Dermatopathol (1992) 1.39

Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet Gynecol (1988) 1.25

Adenocarcinoma of the cervix associated with human papillomavirus. Cancer (1988) 1.09

Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype. Carcinogenesis (2000) 1.04

Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix. Obstet Gynecol (1989) 1.00

Erythropoietin enhances recovery from cisplatin-induced acute renal failure. Am J Physiol (1994) 1.00

Facilitation of recovery from inactivation by external Na+ and location of the activation gate in neuronal Na+ channels. J Neurosci (2000) 0.98

Clinical and histologic features of vulvar carcinomas analyzed for human papillomavirus status: evidence that squamous cell carcinoma of the vulva has more than one etiology. Hum Pathol (1991) 0.94

Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model. Gynecol Oncol (2000) 0.93

A phase I study of weekly cisplatin and whole abdominal radiation for the treatment of stage III and IV endometrial carcinoma: a Gynecologic Oncology Group pilot study. Gynecol Oncol (1996) 0.92

Human papillomavirus type 6 in squamous cell carcinoma of the bladder and cervix. Hum Pathol (1993) 0.91

Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions. Cancer Res (1997) 0.90

[Acute torsion of greater omentum. Report of a case mimicking acute appendicitis]. Zhonghua Yi Xue Za Zhi (Taipei) (1989) 0.88

Characterization of a human ovarian carcinoma cell line: UCI 101. Gynecol Oncol (1993) 0.88

A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN. Gynecol Oncol (1996) 0.85

Spectral editing of two-dimensional magic-angle-spinning solid-state NMR spectra for protein resonance assignment and structure determination. J Biomol NMR (2012) 0.83

Activated pulmonary vascular neutrophils as early mediators of endotoxin-induced lung inflammation. Am J Respir Cell Mol Biol (1993) 0.83

Conservative management of extramammary Paget's disease of the vulva. Gynecol Oncol (1989) 0.81

Meningioma-like tumor of the skin. An ultrastructural and immunohistochemical study. Am J Surg Pathol (1993) 0.80

Recurrent oncocytoma of the ethmoid sinus with orbital invasion. Otolaryngol Head Neck Surg (1985) 0.80

Effects of experimental hemosiderosis on intestinal morphology, permeability, and tissue iron content. Dig Dis Sci (1996) 0.80

Surgical outcome of traumatic intracranial hematoma at a regional hospital in Taiwan. J Trauma (1999) 0.80

Intratumoral oxygenation of invasive squamous cell carcimoma of the vulva is not correlated with regional lymph node metastasis. Eur J Gynaecol Oncol (2005) 0.79

Cellular fibroma masquerading as ovarian carcinoma. Obstet Gynecol (1990) 0.79

Contralateral temperature changes of the finger surface during video endoscopic sympathectomy for palmar hyperhidrosis. J Auton Nerv Syst (1996) 0.78

Intraperitoneal cisplatin: comparison of antitumor activity and toxicity as a function of solvent saline concentration. Gynecol Oncol (1989) 0.78

Cyclosporin enhancement of cisplatin chemotherapy in patients with refractory gynecologic cancer. A Gynecologic Oncology Group Study. Cancer (1994) 0.77

Expression of glial fibrillary acidic protein by neoplastic cells of müllerian origin. Virchows Arch B Cell Pathol Incl Mol Pathol (1986) 0.77

[Transcriptome analysis of human breast cancer cell lines MCF-7 and MDA-MB- 435 by RNA-seq]. Mol Biol (Mosk) (2015) 0.77

Urinary concentrating defect in experimental hemochromatosis. J Am Soc Nephrol (1996) 0.76

Immunohistochemical analysis, human papillomavirus DNA detection, hormonal manipulation, and exogenous gene expression of normal and dysplastic human cervical epithelium in severe combined immunodeficiency mice. J Virol (1999) 0.76

Primary lung choriocarcinoma masquerading as a metastatic gestational neoplasm. Gynecol Oncol (1994) 0.76

Identification of a novel human testicular interstitial gene, RNF148, and its expression regulated by histone deacetylases. Genet Mol Res (2013) 0.76

Use of a murine model for comparison of intravenous and intraperitoneal cisplatin in the treatment of microscopic ovarian cancer. Gynecol Oncol (1988) 0.75

Gate length scaling effect on high-electron mobility transistors devices using AlGaN/GaN and AlInN/AlN/GaN heterostructures. J Nanosci Nanotechnol (2014) 0.75

Arabinoxylans from rye and wheat seed that interact with ice. Carbohydr Res (1989) 0.75

The use of molecular probes to distinguish new primary tumors from recurrent tumors in gynecologic malignancies. Am J Clin Pathol (1990) 0.75

Multiple periorbital fibrous histiocytomas. A possible variant of multiple xanthogranulomas. Int J Dermatol (1991) 0.75

Giant cell fibroblastoma: an immunohistochemical study. J Cutan Pathol (1986) 0.75

Multiple eruptive benign keratoses associated with cyclosporine therapy for psoriasis. J Am Acad Dermatol (1992) 0.75

Endocrine and tumor differentiation markers in poorly differentiated small-cell carcinoids of the cervix and vagina. Arch Pathol Lab Med (1986) 0.75

Toxicity of the mitochondrial poison dequalinium chloride in a murine model system. J Pharm Sci (1993) 0.75

Signet ring cell basal cell carcinoma. Am J Dermatopathol (1991) 0.75

Intracerebral hemorrhage caused by cerebral amyloid angiopathy: a case report. Zhonghua Yi Xue Za Zhi (Taipei) (1999) 0.75

Quantitative nuclear DNA analysis of human ovarian adenocarcinoma: compared before and after chemotherapy and correlated with clinical response. Gynecol Oncol (1986) 0.75

Detection of adulteration of anti-hypertension dietary supplements and traditional Chinese medicines with synthetic drugs using LC/MS. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2010) 0.75